Naturecell네이처셀
007390 · KOSDAQ · ₩007390 · 네이처셀
₩22,300▲ ₩500 (2.29%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩21B | ₩32B | ₩19B | ₩22B | ₩22B |
| Cost of sales | ₩11B | ₩15B | ₩11B | ₩12B | ₩13B |
| Gross profit | ₩9.5B | ₩17B | ₩8.2B | ₩9.3B | ₩9.4B |
| Operating income | −₩3.6B | ₩598M | −₩10B | −₩9.5B | −₩9.5B |
| Net income | −₩2.8B | ₩1.2B | −₩12B | −₩6.8B | −₩32B |
| Net income to shareholders | −₩2.8B | ₩1.2B | −₩12B | −₩6.8B | −₩32B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩75B | ₩72B | ₩68B | ₩94B | ₩70B |
| Current assets | ₩29B | ₩42B | ₩41B | ₩67B | ₩43B |
| Cash and equivalents | ₩17B | ₩28B | ₩30B | ₩31B | ₩33B |
| Total liabilities | ₩12B | ₩7.4B | ₩7B | ₩37B | ₩8.8B |
| Current liabilities | ₩8.7B | ₩4.1B | ₩4.2B | ₩36B | ₩6.6B |
| Borrowings | ₩5B | ₩130M | — | ₩24B | ₩0 |
| Total equity | ₩63B | ₩65B | ₩61B | ₩57B | ₩61B |
| Shareholders' equity | ₩63B | ₩65B | ₩61B | ₩57B | ₩61B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩157M | ₩1.5B | −₩2.1B | −₩15B | −₩10B |
| Capital spending | ₩17B | ₩3.1B | −₩6.1B | −₩3.8B | −₩384M |
| Free cash flow | −₩16B | −₩1.6B | −₩8.3B | −₩19B | −₩11B |
Consolidated where available. Amounts in won.
Also known as: Naturecell / 네이처셀 / 007390 / KRX:007390
Source: KRX statistical information